Study Finds Rare Gain for Tough-To-Treat Pancreatic Cancer

By THE ASSOCIATED PRESS
NYT
Patients with pancreatic cancer that hadn't spread lived substantially longer on a four-drug combo than on a single standard cancer drug, a rare advance for a tough-to-treat disease, researchers reported Monday.
Published date: June 4, 2018 at 02:42PM
AP
New York Times article